Skip to content
Companies

AIQ Global

Lesion-level tumor response analysis from PET and CT

Raised to date

$1.4M

of $3M offered across 1 Form D filing

Still open
$1.6M
Investors
10
Last filed
Mar 23, 2026

About

AIQ Global (operating as AIQ Solutions) is a Madison, Wisconsin company that builds software medical devices for quantitative analysis of oncology imaging. Its platform reads serial radiographic scans (PET and CT) and measures how individual lesions change over time, so oncologists can see treatment response that whole-body summary measures miss. The technology targets late-stage metastatic disease, where different lesions in the same patient respond differently to the same therapy. The company's lead product is FDA-cleared for clinical use.

Quantifies intra-patient lesion heterogeneity from routine PET/CT scans rather than reporting a single whole-body response score, and the company reports its SUVhetero metric prognosticates progression better than standard RECIST and PERCIST criteria.

Funding

  • DebtFiled Mar 23, 2026Form D
    $1.4M/ $3M

Product

TRAQinform IQ

Software medical device / medical imaging analysis

A software medical device that analyzes serial radiographic images to quantify changes in regions of interest across a patient's disease burden over time, producing a report for the treating oncologist.

  • Quantifies intra-patient lesion heterogeneity across serial PET/CT scans
  • SUVhetero metric for predicting progression outcomes
  • FDA 510(k) cleared (K173444, K233998)

Built for

Oncologists, hospitals, and cancer centers treating advanced metastatic disease, including lung cancer, lymphoma, and prostate cancer

People on file